First Time Loading...

Interpace Biosciences Inc
OTC:IDXG

Watchlist Manager
Interpace Biosciences Inc Logo
Interpace Biosciences Inc
OTC:IDXG
Watchlist
Price: 1.45 USD
Updated: May 15, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

13m
-9%
Assets
Growth Rates:
1 Year
-19%
3 Years
-72%
5 Years
-58%
7 Years
-69%
10 Years
-81%
28.2m
-7%
Liabilities
Growth Rates:
1 Year
-13%
3 Years
0%
5 Years
+79%
7 Years
-20%
10 Years
-23%
-15.1m
+6%
Equity
Growth Rates:
1 Year
+8%
3 Years
-
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
Interpace Biosciences Inc

13m
Assets
28.2m
Liabilities
13m
Assets
28.2m
Liabilities
Current Assets 10.3m
Cash & Short-Term Investments 3.5m
Receivables 5m
Other Current Assets 1.8m
Non-Current Assets 2.7m
PP&E 2.7m
Other Non-Current Assets 45k
Current Liabilities 17.5m
Accounts Payable 1.5m
Accrued Liabilities 9.4m
Other Current Liabilities 6.5m
Non-Current Liabilities 10.7m
Long-Term Debt 4.2m
Other Non-Current Liabilities 6.4m

Balance Sheet
Interpace Biosciences Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
23
8
1
15
6
2
3
3
5
3
Cash Equivalents
23
8
1
15
6
2
3
3
5
3
Short-Term Investments
0
0
0
0
0
0
0
0
0
0
Total Receivables
6
4
3
3
10
10
8
6
5
5
Accounts Receivables
4
3
2
3
10
10
8
6
5
5
Other Receivables
2
1
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
0
2
2
2
1
1
Other Current Assets
16
7
1
1
2
2
1
1
1
1
Total Current Assets
45
19
4
20
18
17
14
12
12
10
PP&E Net
2
2
1
1
1
11
12
10
3
3
PP&E Gross
2
2
1
0
1
11
12
10
3
3
Accumulated Depreciation
18
20
6
0
1
2
3
4
2
3
Intangible Assets
47
44
36
33
13
16
11
7
1
0
Goodwill
16
0
0
0
0
8
8
8
0
0
Other Long-Term Assets
6
4
0
0
0
0
0
0
0
0
Other Assets
16
0
0
0
0
8
8
8
0
0
Total Assets
116
N/A
68
-42%
42
-38%
54
+28%
31
-42%
52
+66%
46
-11%
38
-16%
16
-58%
13
-19%
Liabilities
Accounts Payable
2
2
2
0
1
5
5
3
1
2
Accrued Liabilities
6
6
8
6
5
9
11
11
9
9
Short-Term Debt
0
0
0
0
0
0
0
0
3
0
Current Portion of Long-Term Debt
0
1
0
0
0
0
0
0
0
5
Other Current Liabilities
25
14
6
1
2
4
2
2
2
1
Total Current Liabilities
34
23
16
8
9
17
18
16
14
17
Long-Term Debt
27
7
8
0
0
3
0
10
11
4
Deferred Income Tax
3
0
0
0
0
0
0
0
0
0
Other Liabilities
33
24
11
6
7
9
10
9
7
6
Total Liabilities
96
N/A
55
-43%
35
-36%
14
-61%
16
+15%
30
+90%
28
-5%
34
+22%
33
-5%
28
-13%
Equity
Common Stock
0
0
0
0
0
27
47
47
47
47
Retained Earnings
100
111
120
132
159
186
212
227
249
248
Additional Paid In Capital
134
133
128
173
176
183
184
186
188
188
Treasury Stock
14
8
2
2
2
2
2
2
2
2
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
20
N/A
13
-35%
7
-50%
40
+514%
15
-61%
22
+41%
18
-19%
4
-77%
17
N/A
15
+8%
Total Liabilities & Equity
116
N/A
68
-42%
42
-38%
54
+28%
31
-42%
52
+66%
46
-11%
38
-16%
16
-58%
13
-19%
Shares Outstanding
Common Shares Outstanding
0
0
0
3
3
4
4
4
4
4
Preferred Shares Outstanding
0
0
0
0
0
0
0
0
0
0

See Also

Summary
IDXG intrinsic value, competitors valuation, and company profile.
DCF Valuation
IDXG stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IDXG stock valuation using valuation multiples.
Wall Street Estimates
IDXG price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IDXG stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.